Market
$2,000 Medicare drug cost cap increased by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from the Centers for Medicare & Medicaid Services (CMS) or legislative updates
Story
Medicare Implements $2,000 Annual Cap on Prescription Drug Costs Under Inflation Reduction Act
Dec 31, 2024, 09:50 PM
Starting January 1, Medicare will implement a new annual cap on out-of-pocket prescription drug costs at $2,000 for beneficiaries, a move anticipated to save millions of Americans money on their medications. This cap, part of the Inflation Reduction Act, will apply to drugs purchased at pharmacies or through mail order, offering significant relief to those who require multiple medications. The provision aims to limit the financial burden on Medicare enrollees, who previously faced no limit on out-of-pocket costs for medications covered by their Part D drug plans.
View original story
Similar markets
Yes • 50%
No • 50%
70% to 90% • 25%
Less than 50% • 25%
50% to 70% • 25%
More than 90% • 25%
More than $2,000 • 25%
$500 to $1,000 • 25%
Less than $500 • 25%
$1,000 to $2,000 • 25%
No • 50%
Yes • 50%
20% to 30% • 25%
10% to 20% • 25%
More than 30% • 25%
Less than 10% • 25%
$5 billion to $10 billion • 25%
More than $15 billion • 25%
$10 billion to $15 billion • 25%
Less than $5 billion • 25%
Less than 50% • 25%
More than 90% • 25%
71% to 90% • 25%
50% to 70% • 25%
Chronic condition medications • 25%
Cancer treatments • 25%
Diabetes medications • 25%
Other • 25%
No • 50%
Yes • 50%
$10 billion to $15 billion • 25%
More than $15 billion • 25%
$5 billion to $10 billion • 25%
Less than $5 billion • 25%